baber/WOPTO huggingface dataset:
Patent IE-34789-B1 (IE)
Title: A stabilized amylase complex and compositions containing them
IPC: C08B30/14
Filed: 1970-12-04
Abstract: 1306990 Detergents containing enzymes PROCTER & GAMBLE CO 8 Dec 1970 [8 Dec 1969] 58226/70 Heading C5D [Also in Division C3] In an example a stabilized amylase composition (see Division C3) is included in a detergent composition comprising sodium linear alkyl benzene sulphonate, sodium terpolyphosphate, sodium silicate, sodium sulphate, fatty acid soap, sodium perborate, miscellaneous brighteners and CMC. The stabilized composition may contain both amylase and protease. The amylase composition may be incorporated in a laundry detergent composition containing 80 to 99% of a surfactant and an inorganic or organic builder in a ratio of surfactant to builder of 4 : 1. The surfactant may be anionic, nonionic or ampholytic including zwitterionic.
[GB1306990A]
Patent IE-41640-B1 (IE)
Title: New antibiotic substances
IPC: A61K35/66
Filed: 1975-07-23
Abstract: 1470407 Antibiotics GKUPPO LEPETIT SpA 25 July 1975 [27 July 1974] 33283/74 Heading C2A Antibiotic substances known as metabolite A metabolite B (referred to herein as gardimycin) and metabolite C are prepared by activating either Actinoplanes garbadinensis ATCC 31049, or Actinoplanes ligurial ATCC 31048 and mutants or equivalents thereof under aerobic conditions in an aqueous medium containing assimilable sources of carbon, nitrogen and inorganic salts until substantial antibiotic activity is present and recovering the antibiotics from the medium. The metabolites may be purified and isolated by known techniques. Gardimycin as the monosodium salt has the following characteristics :- 1. M.Pt : 260‹ C. (decomposition) 2. M.Wt : 2005-2168 3. Elemental analysis 4. U.V. absorption bands Solvent 2 max.(m) E 1% 1 cm methanol 273 (shoulder) 280 26 299 24 sodium hydroxide 0À1N 273 (shoulder) 279 26 288 22 hydrochloric acid 0À1N 273 (shoulder) 279 26 288 22 phosphate buffer 273 (shoulder) pH 7À38 279 24 288 20 The complete spectrum is illustrated in Fig. 1 (not shown). 5. I.R. spectrum; characteristic absorption bands in mijol at the following frequencies (cm.-1) : 3280, 2920-2840 (mijol), 1650, 1520, 1455 (mijol), 1375 (mijol), 1260, 1045, 999, 720. The complete spectrum is illustrated in Fig. 2 (not shown). 6. Specific rotation 7. Solubility Soluble in water, aqueous sodium bicarbonate, diluted aqueous solutions of alkali hydroxides, hot methanol, dimethylformamide, dimethylsulfoxide, glacial acetic acid. Insoluble in dilute mineral acids, benzene, acetone, chloroform, carbon tetrachloride, (C 2-6 ) aliphatic alkanols and tetrahydrofuran. 8. Characteristic reactions 9. Ionizable functionsan ionizable function is potentiometrically detected with a pKa = 7À1 (water) and a pKa = (methyl cellosolve : water = 16 : 4). 10. Iso electric point 4À2 (determined by electrofocusing). 11. Rf values chromatography on Whatman paper No. 1; visualization of the spots by microbiological development on Staphylococcus aureus. Eluting System Rf values (1) Butanol saturated with phos- 0À15 phate buffer M/15 pH 6À0 (2) Butanol saturated with water 0À80 containing 2% p-toluenesulfonic acid (3) Butanol saturated with water 0À10 containing 2% of ammonium hydroxide (4) Phosphate buffer M/15 pH 6À0 0À80 saturated with butanol (5) 20% aqueous solution of 0À80 sodium hydroxide (6) Butanol : methanol : water = 0À65 40 : 10 : 20 with 0À75% of methyl orange (7) Butanol : methanol : water = 0À60 40 : 10 : 20 (8) Acetone : water=1 : 1 0À80 (9) Ethyl acetate saturated with 0À00 water 12. t.l.c. on silica gel; visualization of the spots by sulfuric acid and vanilline and microbiological development of Staphylococcus aureus. Eluting system Rf value Ammonium hydroxide : 0À70 ethanol : water = 1 : 8 : 1 13. The antibiotic is further characterized by the following acids which are obtained by hydrolysis with HCl:- Acid Approx. ratio Valine 2 Serine 1 Glycine 2 Glutamic acid 1 Isoleucine 2 Leucine 1 Alanine 1 Tryptophan 1
Patent IE-37198-B1 (IE)
Title: A multi-blank container
IPC: B31B50/44
Filed: 1972-12-01
Abstract: 1376454 Making boxes AIRFIX INDUSTRIES Ltd 11 Dec 1972 [14 Dec 1971] 58080/71 Heading B5D To enable blanks used to form boxes to be positioned close together on the blank stackwhich may be flexible board, paper, plastics or metal foil-without wastage each box is formed of two or more blanks the abutting edges of which are connected, preferably by injection moulding. The blanks may be frusto-conical as shown in Fig. 2 or rectangular if the box is to be rectangular. A base may be formed of overlapping flaps secured together by injection moulding or the base may be formed by injection moulding. Apparatus for assembling the blanks comprises stacks of blanks 14, 15, and arms 22, 23 having suction pads 24 and swingable by the action of a jack 27 to remove blanks from the stacks and present them to the cavity of a tool 21. Actuation of a further jack 20 moves the blanks and arms 22, 23 into the cavity with the blank edges abutting. Vacuum ports may be provided in the walls of the cavity. The cavity tool is then closed by a core tool that injects material to form the seams, and if required the base. There may be two cavity tools mounted on rails so that they can be moved into and out of the moulding machine, one tool being loaded with blanks whilst the seams are being moulded in the other tool. When the blanks include base forming flaps an additional member (30, Fig. 7) having a suction cap is provided on the arms 22, 23.
[GB1376454A]
Patent IE-50852-B1 (IE)
Title: Substituted benzophenone hydrazones,pesticidal compositions containing them and method of combating pests
IPC: C07F9/06
Filed: 1980-08-29
Abstract: Substituted benzophenone hydrazones of formula I 
<CHEM>
 in which R, Q, R<2> and R<4> have the meaning given in the description. 
<??>The hydrazones have pesticidal activity, especially againct insects and acarids, and pesticidal compositions and methods are described. Methods of making the hydrazones are also described.
Patent IE-53804-B1 (IE)
Title: N-methyl-d-glucamine salt
IPC: A61P27/16
Filed: 1982-08-20
Abstract: Treatment of the antiallergic agent 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2 -carboxylic acid with N-methyl-D-glucamine gives a salt with improved solubility. Solutions of this salt have pH values in a range acceptable for topical formulations. Additionally, solutions of the subject salt exhibit good stability which can be demonstrated by retention of potency. The salt is comprised of a 1:1 molecular ratio of the glucamine base to the acid.
Patent IE-45938-B1 (IE)
Title: 1-phenoxy-3-amino-propan-2-ols
IPC: C07C67/00
Filed: 1977-10-06
Abstract: The process is used for preparing the novel amines of the formula (I)  R<1>, R<2> and R<3> are defined in Patent Claim 1. The reactions for preparing the said compounds always take place between primary amines and compounds having a reactive, esterified hydroxyl group or an epoxy group. The novel compounds effectively block beta receptors.
Patent IE-43592-B1 (IE)
Title: Improvements in or relating to organic compounds
IPC: A61K36/06
Filed: 1975-10-06
Abstract: 1527494 Antibiotic SANDOZ Ltd 2 Oct 1975 [7 Oct 1974 12 Dec 1974 12 Feb 1975 7 April 1975 24 July 1975] 40301/75 Heading C2C A process for producing a compound selected from antibiotics SL 7810/F, SL 7810/F-II and SL 7810/F-III and their tetrahydro derivatives comprises (a) cultivating a SL 7810/F and/or SL 7810/F-II and/or SL 7810/F-III producing strain of Aspergillus rugulosus Thorn and Raper in the presence of a nutrient medium to produce one or more of the above antibodies or (b) hydrogenating an antibiotic chosen from SL 7810/F, SL 7810/F-II and SL 7810/F-III to produce the corresponding tetrahydro derivative. The strain used is suitably NRRL 8039. The compound may be mixed with a suitable diluent or carrier to form a pharmaceutical composition. Antibiotic SL 7810/F has the formula wherein R is Antibiotic SL 7810/FII has the formula wherein R is as above. Antibiotic SL 7810/F-III has the formula wherein R is as above.
Patent IE-49469-B1 (IE)
Title: Substituted quinazolines
IPC: C07D239/80
Filed: 1979-12-07
Abstract: Substituted quinazolines of the formula  wherein R1 is H, C4-20 alkyl, cycloalkyl, heterocycloalkyl, halo, COOC1-6 alkyl, CN, COOH, CH2OH, CH(OC1-6 alkyl)2 or NO2; and X and Y are each H, halo, NO2, C1-6 alkyl, C1-6 alkoxy, aryl, aralkyloxy, HO, acyloxy, aryloxy, amino, C1-6 alkylamino di C1-6 alkylamino, amido, C1-6 alkylamido, di C1-6 alkylamido, CN, COOH, COOC1-6 alkyl, CHO, CH2OH, CH2O acyl, or CH2O aryl and pharmaceutically acceptable acid addition salts thereof, provided that when X and Y are C1-6 alkoxy R1 is not H are useful for the treatment of hypertension and bradycardia and as cardiotonic agents.
Patent IE-61160-B1 (IE)
Title: Self-adhesive product
Inventor: PAELLI KARI
IPC: C09J7/20
Filed: 1987-10-23
Abstract: A self-adhesive product according to the invention com­prises two opposing surface layers (1, 2). Therebetween is laid a release layer (4, 5) and an adhesive layer (6). Release layer (4, 5) consists of two components in a manner that a first release layer component (4) is formed as a part of first surface layer (1) and a second release layer component (5) is similarly formed as a part of second surface layer (2). At said first release layer component (4), said adhesive layer (6) extends substantially to second surface layer (2) and vice versa.
Patent IE-65639-B1 (IE)
Title: 4,5,6,7-Tetrahydrobenzimidazole derivatives and their preparation
Inventor: OHTA MITSUAKI
IPC: C07D235/08
Filed: 1989-12-21
Abstract: 4,5,6,7-Tetrahydrobenzimidazole derivatives (I) and salts thereof show 5-HT3 antagonizing activity <CHEM>  wherein R<1>, R<2>, R<3> independently represent hydrogen atom, hydroxy group, a halogen atom, a lower alkyl group which may optionally be substituted with a halogen atom, a lower alkoxy group, a lower alkylthio group, an aralkyloxy group, an aryloxy group, a lower alkanoyl group, carboxy group, a lower alkoxycarbonyl group or nitro group; R<4>,R<5> and R<6> can each be a hydrogen atom or a lower alkyl group; and X is an oxygen atom or sulfur atom. d
Patent IE-80593-B1 (IE)
Title: A conveyor roller
Inventor: MURPHY JAMES
IPC: B65G13/00
Filed: 1997-04-03
Abstract: A conveyor roller (1) comprises an elongate cylindrical roller body (2) having a pair of end covers (3). A central support spindle (4) is rotatably mounted in bearings (5) in each of the end covers (3) and projects through an opening (9) in at least one of the end covers (3). A rotating contact seal (6) is provided between the spindle (4) and each bearing (5). The end cover (3) through which the spindle (4) projects is counterbored at (10) to receive a primary static seal (12,30,37). The seal (12,30,37) comprises an axial sealing section (15) which is a tight fit on and extends partially along the spindle (4) and a radial sealing section 16 which extends radially outwardly of the axial section (15) and is received in the counterbore (10) of the end cover (3). An effective seal is thus provided against ingress of moisture and dirt to the bearings (5). .
Patent LU-101233-B1 (LU)
Title: Package for foodstuff products
Inventor: BORIO PIERANGELO
IPC: B65D85/60
Filed: 2019-05-23
Granted: 2020-11-23
Abstract: BL-5089 ABSTRACT Described herein is a package (10) for a foodstuff product, in particular a confectionery product, comprising: - an outer wrapper (2) that envelops said product (P) 5 completely so as to define a closed chamber (C) containing said product; and - a support (4), set on which is said product (P), which is housed within said closed chamber (C) together with said product (P). 10 The package is characterised in that said support (4) comprises a base (41) on which said product rests, and lateral walls (411, 4III, 4IV, 4V) that surround said product, wherein said lateral walls include a pair of lateral walls (411, 4IV) that are set in positions opposed 15 to one another with respect to said product (P) and have a height such as to project above said product (P). (Figure 2) - 11 -
Patent LU-500344-B1 (LU)
Title: Tool for determining a position of a dispensing head
Inventor: MAZHAR UMAIR
IPC: G01N35/10
Filed: 2021-06-29
Granted: 2022-12-29
Abstract: The invention relates to a tool for determining a position of a dispensing head of a dispensing device for dispensing liquid sample, with a tool body that is configured to be insertable in a recess of a holder of the dispensing device in a rotationally fixed manner and at least two sensors for measuring a physical value characterizing the position of the dispensing head, wherein the sensors are arranged on or in the tool body.
Patent LU-501257-B1 (LU)
Title: Method and apparatus for estimating grid-scale tension water storage capacity, and storage medium
Inventor: ZHANG KE
IPC: G06Q50/26
Filed: 2022-01-18
Granted: 2023-01-10
Abstract: The present invention discloses a method and apparatus for estimating a grid-scale tension water storage capacity, and a storage medium. The method includes the following steps: firstly, calculating a topographic index of each grid cell in a basin; then, obtaining a phreatic water evaporation limit depth, a field capacity and a wilting water content of each grid cell; thereafter, deducing an evaporable aeration zone thickness of the grid cells; and finally, acquiring an impermeable area proportion of each grid cell in the basin, and deducing the spatial distribution of tension water storage capacity in the basin in combination with the evaporable aeration zone thickness, the field capacity and the wilting water content of each grid cell. A method for estimating a tension water storage capacity of a grid cell based on an evaporable aeration zone thickness and an impermeable area proportion is proposed in the present invention. In consideration of the influence of human activities and natural geographical conditions on the spatial distribution of tension water storage capacity, the problem that the existing estimation methods cannot better reflect the influence of human activities on the spatial distribution of tension water storage capacity is solved.
Patent LU-504454-B1 (LU)
Title: Molecular markers for distinguishing dafang line peppers and dafang wrinkled peppers and application thereof
Inventor: HUANG DONGFU
IPC: A01H1/04
Filed: 2023-06-08
Granted: 2023-12-11
Abstract: The invention relates to the field of biotechnology, in particular to molecular markers for distinguishing Dafang line peppers and Dafang wrinkled peppers and application thereof, and molecular marker combination comprises molecular markers chr4-InDel-8, chr5-InDel-22, chr6-InDel-8, chr7-InDel-39, chr10-InDel-39 and chr11-indel-38. According to the invention, six pairs of InDel molecular marker primers evenly distributed on six chromosomes are screened out, and after PCR amplification is respectively carried out on the Dafang line pepper and the Dafang wrinkled pepper by using the six pairs of InDel molecular marker primers, the amplified PCR products are subjected to 3% agarose gel electrophoresis to obtain an identification gel map, and then the identification gel map is converted into a 0,1 data matrix, and the Dafang line pepper and the Dafang wrinkled pepper can be identified according to the 0,1 data matrix.
Patent LU-504761-B1 (LU)
Title: Multi angle spectrum sharing method for 5g communication systems
Inventor: XIE YUPENG
IPC: H04W16/10
Filed: 2023-07-18
Granted: 2024-01-18
Abstract: The present invention discloses a multi angle spectrum sharing method for 5G communication systems, and relates to a spectrum sharing method. In the basic model adopted in the wireless system of the present invention, the spectrum information randomly released by the AU and the spectrum resource requirements of each SU are uniformly collected and managed by the spectrum management center set by the system. Spectrum sharing can be studied in the frequency domain, time domain, and spatial domain. A multi angle spectrum sharing method is proposed for 5G communication systems, analyzing the percentage of the total spectrum that can be shared in the system to the total spectrum owned by AU. The competition between CU in the frequency domain, the number of CU in space and the number of available channels, and the conflict between CU and AU in the time domain are analyzed.
Patent NO-301176-B1 (NO)
Inventor: WATANABE SUSAN MITSUE
IPC: A61K35/76
Filed: 1986-04-08
Abstract: A method for expressing proteins which are immunologically reactive with antibodies to lymphadenopathy-associated virus (LAV) is disclosed. The proteins are produced by bacterial host cells transformed with a recombinant plasmid which includes appropriate procaryotic transcriptional and translational signals for expression, followed in reading phase by a DNA sequence comprising a portion of the env region of the LAV genome. This portion codes for a protein which is immunologically reactive with antibodies to LAV, or antibodies to viruses defined to be the same as or equivalent to LAV. The proteins produced by the method disclosed may be used to screen for the presence of antibodies to LAV in a biological fluid, to determine the presence of LAV antigen in a biological fluid, or within a method for producing antibodies to LAV through the immunization of an animal with the protein.
Patent NO-307244-B1 (NO)
Inventor: TOURNIER HERVE
IPC: A61K49/00
Filed: 1994-04-12
Abstract: Magnetite particles suitable for injection into the blood stream of patients having enhanced resistance against agglomeration and uptake by the RES of the liver and spleen. The particles essentially consist of an iron oxide core and a phosphoric acid mono alkyl or alkenyl ester or glycerophospholipid/surfactant three dimensional shell surrounding the core. The core and the monoester or a micellar glycerophospholipid form an urchin-like structure which is further interlaced or intertwined with a non-ionic surfactant to produce a protective three dimensional shell which renders particles almost undetectable by the macrophages. Particles prepared according to the invention are kept in the blood circulation for long periods and represent excellent long lasting blood pool agents. Key components in the shell are (a) a polybasic mineral-organic species such as glycero phosphatidic acid in micellar form and (b) a block copolymer having successive hydrophilic and hydrophobic segments.
Patent NO-309897-B1 (NO)
Title: FremgangsmÕte for Õ fremstille 1,3-propandiol
Inventor: ARHANCET JUAN PEDRO
IPC: C07C45/80
Filed: 1998-09-07
Abstract: 1,3-Propandiol fremstilles ved en fremgangsmåte hvor etylenoksid omsettes med karbonmonoksid og hydrogen i et løsningsmiddel som hovedsakelig ikke er blandbart med vann, i nærvær av en effektiv mengde av en ikke-fosfinligert koboltkatalysator og en effektiv mengde av en katalysatoraktivator under reaksjonsbetingelser som er effektive til frembringelse av en mellomproduktblanding omfattende mindre enn 15 vekt% 3-hydroksypropanal. 3-Hydroksypropanalet ekstraheres i vann fra produktblandingen i mer konsentrert form, idet hovedmengden av koboltkatalysatoren blir tilbake i løsningsmiddelfasen for resirkulering til hydroformyleringsreaksjonen. I det minste en del av eventuell restkatalysator i vannfa-sen etter ekstrahering fjernes ved re-ekstrahering med løsningsmiddel som ikke er blandbart med vann, og resirkuleres til hydroformylering. 3-Hydroksypropanalet blir så hydrogenert i vandig løsning til den ønskede 1,3-propandiol.
Patent AT-516398-B1 (AT)
Title: Vorrichtung einer mit Wärmeträgermedium beheizten gerillten Zylinderinnenfläche
Inventor: ICKINGER GEORG MICHAEL DIPL ING DR TECHN
IPC: F28F5/02
Filed: 2014-12-01
Granted: 2016-05-15
Abstract: Trockenzylinder und vor allem Yankeezylinder von Tissue Anlagen arbeiten als drehende Druckgefäße. Der Vorteil der gleichmäßigen Wärmeverteilung durch Kondensieren von Dampf am Zylinderinnenmantel wird durch ein sehr hohes Druckvolumen (Innendruck x Volumen) erreicht und damit mit großen Sicherheitsreserven und somit hohen Kosten wegen der Dimensionierung und der Qualitätssicherung. Vor allem beim Yankee Zylinder ist der Aufwand des Kondensat-Schöpfens sehr groß. Die vorliegende Erfindung erzielt durch sehr hoher Strömungsgeschwindigkeit und durch eine hohe Temperatur einen verbesserten Wärmeübergang in den Rillen und somit an den Zellstoff . Durch die Technologie aus AT 390 975 der gleichmäßigen Wärmeverteilung durch die Rillengestaltung wird es möglich den Ansprüchen der Tissue Erzeugung auch bei dieser Herstellmethode gerecht zu werden. Sehr geringes Druckvolumen innerhalb der gerillten Zylinderinnenflächen und kostengünstige Herstellung mittels vorgewalzten, gerippt geschweißten oder gezogenen Blechen ergibt einen weiteren Kostenvorteil oder im Gegenzug eine kleinere Dimensionierung der Trockenzylinder oder Kapazitätsvergrößerung bei gleicher Größe.
Patent BG-62307-B1 (BG)
Title: Motor with built-in reduction gear
Inventor: NAST JEAN-DANIEL
IPC: F16H57/02
Filed: 1994-08-30
Abstract: The motor is used in driving electrical machines. It hassimplified and effective ventilation of the bearings unit andgreater speed of the revolutions of over 4000 r.p.m. It consistsof a revolving motor (1) the driving shaft (2) of which isconnected to a driving gear (3) transmitting the rotative motionof an output gear (4) by means of an intermediate gear (5) meshedto gears (3 & 4). First (6) and second (7) bearings unit arefitted on the driving shaft (2), on one of the motor's side (1)and on the other side of motor (1) as well as on the driving gear(3). Box (8) of the motor is placed around it and the firstbearings unit (6) rests on it. The reducing gear box (9) is fittedaround the driving (3), the intermediate (5) and outlet (4) gearand on it the second bearings unit (7) rests. The reducing gearbox (9) is cooled by part of the forced ventilation designed forcooling the motor box (8).5 claims, 2 figures
Patent BR-0100976-B1 (BR)
Inventor: ONISHI KAZUAKI
IPC: A61F13/15
Filed: 2001-03-07
Abstract: A sanitary article having a multi-layered absorbent member 1 includes a panel H stacked in two layers each having a plurality of openings H extending through this member 1 in its thickness direction and a plurality of fibrous assembly regions R extending between each pair of the adjacent openings, the openings H in the upper layer of the panel P are out of alignment with the corresponding openings H in the lower layer of the panel H and each of the openings H in the upper layer of the panel P is divided in two or more sections by the fibrous assembly regions in the lower layer of the panel P. <IMAGE>
Patent BR-PI0107715-B1 (BR)
Inventor: BALKAN BOERK
IPC: A61P3/00
Filed: 2001-01-19
Abstract: The invention relates to a combination which comprises a DPP-IV inhibitor (preferably NVP LAF237 (vildagliptin) or NVP-DPP728) and at least one further antidiabetic compound, preferably selected from the group consisting of insulin signalling pathway modulators, like inhibitors of protein tyrosine phosphatases (PTPases), non-small molecule mimetic compounds and inhibitors of glutamine-fructose-6-phopshate amidotransferase (GFAT), compounds influencing a dysregulated hepatic glucose production, like inhibitors of glucose-6-phosphatase (G6Pase), inhibitors of fructose-1,6-bisphosphatase (F-1,6-BPase), inhibitors of glycogen phosphorylase (GP), glucagon receptor antagonists and inhibitors of phosphoenolpyruvate carboxykinase (PEPCK), pyruvate dehydrogenase kinase (PDHK) inhibitors, insulin sensitivity enhancers, insulin secretion enhancers, ±-glucosidase inhibitors, inhibitors of gastric emptying, insulin, and ± 2 -adrenergic antagonists, for simultaneous, separate or sequential use in the prevention, delay of progression or treatment of conditions such as type 2 diabetes mellitus, impaired glucose tolerance (IGT), impaired fasting plasma glucose, metabolic acidosis, ketosis, arthritis, obesity and osteoporosis.